Beyond Medical Technologies Stock Performance

DOCKF Stock  USD 0.07  0.00  0.00%   
Beyond Medical holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -335.1, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Beyond Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, Beyond Medical is expected to outperform it. Use Beyond Medical standard deviation and the relationship between the jensen alpha and day typical price , to analyze future returns on Beyond Medical.

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Beyond Medical Technologies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting forward-looking signals, Beyond Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:10
Dividend Date
2020-05-12
Last Split Date
2022-12-30
1
What to expect in US healthcare in 2025 and beyond - McKinsey
01/10/2025
2
10 Years From Now, Youll Be Glad You Bought These Magnificent TSX Dividend Stocks - Yahoo Canada Finance
01/29/2025
3
Beyond Medical Welcomes AI Visionary Hongming Luo in Strategic Board Appointment - StockTitan
02/04/2025
4
Beyond Medical Technologies Inc. announced that it expects to receive CAD 0.375 million in funding - Marketscreener.com
02/12/2025
5
Beyond Medical Technologies Secures 375,000 in Private Placement and Appoints New COO - TipRanks
02/24/2025
6
Meet Max Kopp The 17-Year-Old Scientist Entrepreneur Redefining Innovation in Med-Tech Aerospace - Markets Insider
03/19/2025
Begin Period Cash Flow536.8 K
Free Cash Flow-527 K
  

Beyond Medical Relative Risk vs. Return Landscape

If you would invest  2.00  in Beyond Medical Technologies on December 27, 2024 and sell it today you would earn a total of  5.00  from holding Beyond Medical Technologies or generate 250.0% return on investment over 90 days. Beyond Medical Technologies is currently producing 15.127% returns and takes up 127.9812% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Beyond, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Beyond Medical is expected to generate 148.95 times more return on investment than the market. However, the company is 148.95 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.02 per unit of risk.

Beyond Medical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Beyond Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Beyond Medical Technologies, and traders can use it to determine the average amount a Beyond Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1182

Best PortfolioBest EquityDOCKF
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 127.98
  actual daily
96
96% of assets are less volatile

Expected Return

 4.96
  actual daily
96
96% of assets have lower returns

Risk-Adjusted Return

 0.12
  actual daily
9
91% of assets perform better
Based on monthly moving average Beyond Medical is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beyond Medical by adding it to a well-diversified portfolio.

Beyond Medical Fundamentals Growth

Beyond Stock prices reflect investors' perceptions of the future prospects and financial health of Beyond Medical, and Beyond Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Beyond Stock performance.

About Beyond Medical Performance

By analyzing Beyond Medical's fundamental ratios, stakeholders can gain valuable insights into Beyond Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Beyond Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Beyond Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 113.37  107.70 
Return On Tangible Assets(7.17)(6.81)
Return On Capital Employed 1.38  1.45 
Return On Assets(7.17)(6.81)
Return On Equity 2.05  2.15 

Things to note about Beyond Medical Techn performance evaluation

Checking the ongoing alerts about Beyond Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Beyond Medical Techn help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Beyond Medical Techn is way too risky over 90 days horizon
Beyond Medical Techn has some characteristics of a very speculative penny stock
Beyond Medical Techn appears to be risky and price may revert if volatility continues
Beyond Medical Techn has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (595.96 K) with loss before overhead, payroll, taxes, and interest of (250.49 K).
Beyond Medical Technologies has accumulated about 877.31 K in cash with (527.04 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 29.0% of the company shares are held by company insiders
Latest headline from news.google.com: Meet Max Kopp The 17-Year-Old Scientist Entrepreneur Redefining Innovation in Med-Tech Aerospace - Markets Insider
Evaluating Beyond Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Beyond Medical's stock performance include:
  • Analyzing Beyond Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Beyond Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Beyond Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Beyond Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Beyond Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Beyond Medical's stock. These opinions can provide insight into Beyond Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Beyond Medical's stock performance is not an exact science, and many factors can impact Beyond Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Beyond Stock analysis

When running Beyond Medical's price analysis, check to measure Beyond Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beyond Medical is operating at the current time. Most of Beyond Medical's value examination focuses on studying past and present price action to predict the probability of Beyond Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beyond Medical's price. Additionally, you may evaluate how the addition of Beyond Medical to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio